跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,859 条关于
“ENPP1 Deficiency”
全部
6,859
临床试验
5,692
药物
150
机构
2
资讯
1,015
去年
Inozyme's INZ-701 Shows Promise in ENPP1 Deficiency Trial with Sustained Phosphate Increases
去年
Inozyme's INZ-701 Shows Promise in ENPP1 and ABCC6 Deficiencies
4个月前
BioMarin's BMN 401 Shows Mixed Results in Phase 3 Trial for Rare ENPP1 Deficiency
去年
BioMarin Acquires Inozyme Pharma for $270 Million, Adding Late-Stage Enzyme Therapy for Rare Genetic Disorder
9个月前
BioMarin Awaits Pivotal INZ-701 Trial Results Following $270M Inozyme Acquisition
去年
Insilico Medicine Develops AI-Designed ENPP1 Inhibitor ISM5939 for Cancer Immunotherapy
去年
Stanford Researchers Develop Novel ENPP1 Inhibitor STF-1623 to Transform Cold Tumors into Immunologically Active Targets
去年
Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
去年
Riboscience's First-in-Class ENPP1 Inhibitor RBS2418 Shows Promising Safety and Efficacy in Phase 1a Cancer Trial
去年
FDA Clears AI-Designed Drug ISM5939 for Solid Tumor Clinical Trials
第 1 页,共 102 页
上一页
下一页